Home > Insider Trading > Filing (0000899243-21-037255)

Filing Details

Accession Number:: 0000899243-21-037255
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-23 09:30:09
Reporting Period:: 2021-09-21

Accepted Time:: 2021-09-23 09:30:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1590750	Viridian Therapeutics Inc.	VRDN	Services-Medical Laboratories (8071)	471187261

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1686157	L.p. Fund Healthcare Fairmount	2001 Market Street, Suite 2500 Philadelphia PA 19103	Yes	No	No	Yes
1769651	L.p. Ii Fund Healthcare Fairmount	2001 Market Street, Suite 2500 Philadelphia PA 19103	Yes	No	No	Yes
1802528	Fairmount Funds Management Llc	2001 Market Street, Suite 2500 Philadelphia PA 19103	Yes	No	Yes	No
1830382	Fairmount Healthcare Fund Ii Gp Llc	2001 Market Street, Suite 2500 Philadelphia PA 19103	Yes	No	No	Yes
1830383	Fairmount Healthcare Fund Gp Llc	2001 Market Street, Suite 2500 Philadelphia PA 19103	Yes	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-09-21	909,000	$11.00	938,233	No	4	P	Indirect	Fairmount Healthcare Fund II LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Fairmount Healthcare Fund II LP

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,859	Indirect	Fairmount Healthcare Fund LP

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Series A Non-Voting Convertible Preferred Stock	$0.00			1,466,673	21,999	Indirect
Common Stock	Series A Non-Voting Convertible Preferred Stock	$0.00			7,413,171	111,192	Indirect

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	1,466,673	21,999	Indirect
	7,413,171	111,192	Indirect

Footnotes

Fairmount Funds Management LLC and Fairmount Healthcare Fund GP LLC have voting power and investment power over the shares of Common Stock and Series A Non-Voting Convertible Preferred Stock held by Fairmount Healthcare Fund LP ("Fund I"). They disclaim beneficial ownership of securities held by Fund I for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.
Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the shares of Common Stock and Series A Non-Voting Convertible Preferred Stock held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.
Following stockholder approval of the conversion of Series A Non-Voting Convertible Preferred Stock into shares of Common Stock, each share of Series A Non-Voting Convertible Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 66.67 shares of Common Stock, subject to certain limitations, including that a holder of Series A Non-Voting Convertible Preferred Stock is prohibited from converting shares of Series A Non-Voting Convertible Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.99% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion.